Separate and concurrent use of methamphetamine and fentanyl: behavioral and neurobiological consequences
- 1Department of Psychology, University of New Mexico , , ,
Abstract
Background: Methamphetamine, a potent psychostimulant, is one of the most used substances globally. When administered alone, methamphetamine has powerful rewarding and reinforcing properties and produces numerous health consequences. However, recent national trends reveal that methamphetamine is increasingly being used concurrently with fentanyl. Of particular concern is that many methamphetamine users are unwittingly exposed to fentanyl, due to the increasing rate at which psychostimulants are “laced” with the opioid. While the amplified health risks of the drug combination, such as potential overdoses, are well documented, their shared addictive potential is less clear.
Methods: In this review, we assessed the current literature on the neurobiological mechanisms associated with concurrent methamphetamine and fentanyl use, as well as the behavioral effects of the combined drugs.
Results: Agonism of μ opioid receptors is a critical system involved in modulating the behavioral effects of methamphetamine and fentanyl, including conditioned place preference, cue-reactivity and behavioral sensitization. The existing literature also suggests that methamphetamine and fentanyl may have synergistic interactions that enhance their addictive potential, effects that are likely mediated by μ opioid receptors.
Conclusion: Concurrent methamphetamine-fentanyl use is a mounting crisis. Unfortunately, the neurobiological and behavioral consequences of this drug combination have not been adequately examined. While the existing literature on concurrent methamphetamine-opioid use indicates that the drugs have synergistic addictive potential, more research specifically examining methamphetamine-fentanyl combinations is needed.
Related
- Psychopharmacological Effects of Cannabidiol in Rodent Models of Autism Spectrum Disorder: A Systematic Review of Behavioral Outcomes, Neurobiological Mechanisms, and Methodological Quality
- Behavioral, Transcriptomic, and Neuroinflammatory Effects of Sleep Deprivation: Insights From Separate Acute and Chronic Experimental Paradigms.
- Concurrent cognitive, behavioral and systemic physiological features mark preclinical Alzheimer's disease
- Central and peripheral plasticity after chemical unilateral labyrinthectomy: Glial responses, calyces dynamics, and behavioral consequences
- Early dopamine elevation modifies the behavioral consequences of maternal separation in female and male juvenile mice
BibTeX
@article{madden2026separate,
title = {{Separate and concurrent use of methamphetamine and fentanyl: behavioral and neurobiological consequences}},
author = {John T. Madden and Benjamin J. Clark and Derek A. Hamilton and Nathan S. Pentkowski},
journal = {Frontiers in behavioral neuroscience},
year = {2026},
month = oct,
doi = {10.3389/fnbeh.2026.1966221},
url = {https://europepmc.org/article/PMC/PMC13728774},
note = {CC BY},
}
RIS
TY - JOUR
TI - Separate and concurrent use of methamphetamine and fentanyl: behavioral and neurobiological consequences
AU - John T. Madden
AU - Benjamin J. Clark
AU - Derek A. Hamilton
AU - Nathan S. Pentkowski
PY - 2026
DA - 2026/10/20
JO - Frontiers in behavioral neuroscience
DO - 10.3389/fnbeh.2026.1966221
UR - https://europepmc.org/article/PMC/PMC13728774
AB - Background: Methamphetamine, a potent psychostimulant, is one of the most used substances globally. When administered alone, methamphetamine has powerful rewarding and reinforcing properties and produces numerous health consequences. However, recent national trends reveal that methamphetamine is increasingly being used concurrently with fentanyl. Of particular concern is that many methamphetamine users are unwittingly exposed to fentanyl, due to the increasing rate at which psychostimulants are “laced” with the opioid. While the amplified health risks of the drug combination, such as potential overdoses, are well documented, their shared addictive potential is less clear. Methods: In this review, we assessed the current literature on the neurobiological mechanisms associated with concurrent methamphetamine and fentanyl use, as well as the behavioral effects of the combined drugs. Results: Agonism of μ opioid receptors is a critical system involved in modulating the behavioral effects of methamphetamine and fentanyl, including conditioned place preference, cue-reactivity and behavioral sensitization. The existing literature also suggests that methamphetamine and fentanyl may have synergistic interactions that enhance their addictive potential, effects that are likely mediated by μ opioid receptors. Conclusion: Concurrent methamphetamine-fentanyl use is a mounting crisis. Unfortunately, the neurobiological and behavioral consequences of this drug combination have not been adequately examined. While the existing literature on concurrent methamphetamine-opioid use indicates that the drugs have synergistic addictive potential, more research specifically examining methamphetamine-fentanyl combinations is needed.
SN - 1662-5153
ER -